Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm receives $1.34 million R&D tax incentive rebate

Mar 22, 2017 at 2:46 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment